Affiliation:
1. South- Central Minzu University
Abstract
Abstract
Background
As a candidate oncogene, PLAC8 participate in genesis and progression of various tumors. However, the role of PLAC8 in lung cancer (LC) especially non-small cell lung cancer (NSCLC) is still limited.
Methods
We performed Tissue microarray analysis (TMA) and Real-Time PCR (RT-PCR) to detect the expression levels of PLAC8 in LC tissues and cell lines, respectively. Then a series of cellular experiments focusing on cell proliferation, cell cycle, cell motility were conducted to identified the role of PLAC8 in NSCLC-derived cell lines H1299 and A549.
Results
TMA and RT-PCR showed that PLAC8 played complicated even opposite roles in different LCs. Further cellular experiments confirmed that PLAC8 could promote cell viability, alter cell cycle, and accelerate cell mobility via regulation of cell cyclins or cadherins, respectively.
Conclusions
Our study indicated that PLAC8 might participate in LC especially NSCLC progression. Our study also shed new light on the potential role of PLAC8 as a therapeutic biomarker in NSCLC.
Publisher
Research Square Platform LLC
Reference47 articles.
1. Nooreldeen R, Bach H. Current and Future Development in Lung Cancer Diagnosis.International journal of molecular sciences22, (2021).
2. Lung Cancer;Nasim F;Med Clin N Am,2019
3. Bade BC, Dela Cruz CS. Lung Cancer 2020: Epidemiology, Etiology, and Prevention. Clinics in chest medicine 41, 1–24 (2020).
4. Wistuba, II, Diagnosis and Molecular Classification of Lung Cancer;Rodriguez-Canales J;Cancer Treat Res,2016
5. Lung cancer in China: current and prospect;Wu F;Curr Opin Oncol,2021